Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Toxicology and Applied Pharmacology
|
August 1, 1991
Evidence for arsenic as the immunosuppressive component of gallium arsenide
L A Burns, E E Sikorski, J J Saady, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1980
Demonstration of major metabolic pathways for chlordecone (kepone) in humans
M W Fariss, R V Blanke, J J Saady, et al.
Psychopharmacology
|
January 1, 1981
A comparison of plasma and serum levels of two tricyclic antidepressants: imipramine and desipramine
J J Saady, V L Bloom, N Narasimhachari, et al.
Journal of Analytical Toxicology
|
October 27, 1998
Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing
A Poklis, J Still, P W Slattum, et al.
Forensic Science International
|
April 1, 1993
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation
A Poklis, K V Hall, R A Eddleton, et al.
Circulation Research
|
November 1, 1982
The effect of O2 and CO2 on prostaglandin levels in the cat cerebral cortex
E F Ellis, E P Wei, C S Cockrell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1996
Perinatal methadone exposure produces physical dependence and altered behavioral development in the rat
P M Kunko, J A Smith, M J Wallace, et al.
Artery
|
January 1, 1982
The effect of tranylcypromine on levels of 6-keto-PGF1 alpha and other prostaglandins in brain and mesentery of the mouse
E F Ellis, W I Rosenblum, D L Birkle, et al.
Brain Research
|
January 13, 1992
Postinjury scopolamine administration in experimental traumatic brain injury
B G Lyeth, M Ray, R J Hamm, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Toxicology and Applied Pharmacology
|
August 1, 1991
Evidence for arsenic as the immunosuppressive component of gallium arsenide
L A Burns, E E Sikorski, J J Saady, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1980
Demonstration of major metabolic pathways for chlordecone (kepone) in humans
M W Fariss, R V Blanke, J J Saady, et al.
Psychopharmacology
|
January 1, 1981
A comparison of plasma and serum levels of two tricyclic antidepressants: imipramine and desipramine
J J Saady, V L Bloom, N Narasimhachari, et al.
Journal of Analytical Toxicology
|
October 27, 1998
Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing
A Poklis, J Still, P W Slattum, et al.
Forensic Science International
|
April 1, 1993
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation
A Poklis, K V Hall, R A Eddleton, et al.
Circulation Research
|
November 1, 1982
The effect of O2 and CO2 on prostaglandin levels in the cat cerebral cortex
E F Ellis, E P Wei, C S Cockrell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1996
Perinatal methadone exposure produces physical dependence and altered behavioral development in the rat
P M Kunko, J A Smith, M J Wallace, et al.
Artery
|
January 1, 1982
The effect of tranylcypromine on levels of 6-keto-PGF1 alpha and other prostaglandins in brain and mesentery of the mouse
E F Ellis, W I Rosenblum, D L Birkle, et al.
Brain Research
|
January 13, 1992
Postinjury scopolamine administration in experimental traumatic brain injury
B G Lyeth, M Ray, R J Hamm, et al.
Page
of 3